Regulators of G-protein signaling (RGS) 1 and 16 are induced in response to bacterial lipopolysaccharide and stimulate c-fos promoter expression

被引:43
作者
Panetta, R
Guo, Y
Magder, S
Greenwood, MT
机构
[1] Royal Victoria Hosp, Montreal, PQ H3A 1A1, Canada
[2] McGill Univ, Dept Anat & Med, Montreal, PQ H3A 1A1, Canada
[3] McGill Univ, Dept Cell Biol, Montreal, PQ H3A 1A1, Canada
基金
英国医学研究理事会;
关键词
D O I
10.1006/bbrc.1999.0817
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Regulators of G-protein signaling (RGS) are negative regulators of G-protein-coupled receptor (GPCR) signaling. Sepsis is a pathophysiological condition that is induced primarily in response to bacterial infection and is associated with decreased responsiveness to a number of vasoactive GPCR agonists. Using a degenerate RT-PCR screen, we report that RGS1 and RGS16 were amplified from the heart and aorta of septic animals. By Northern blot analysis, RGS1 and RGS16 were upregulated, with their respective levels increasing 6- and 50-fold in septic hearts. Using a yeast-based bioassay, both RGS1 and RGS16 were found to be equipotent in their ability to attenuate GPCR signaling. These results suggest that both RGS1 and RGS16 contribute to the sepsis-mediated decrease in GPCR signaling. Elevated levels of some RGSs may also lead to an increase in G(beta gamma)-activated signaling pathways in the absence of GPCR agonists. Using a c-fos luciferase reporter gene that is responsive to G(beta gamma)-activated signaling pathways, we observed a respective 8- and 7-fold increase in the basal luciferase in serum-deprived transfected mammalian cells overexpressing RGS1 or RGS16. This suggests that RGSs play a role in promoting the sepsis-mediated increases in the activation of intracellular signal transduction pathways. (C) 1999 Academic Press.
引用
收藏
页码:550 / 556
页数:7
相关论文
共 45 条
[11]  
Downey J. S., 1998, FRONT BIOSCI, V3, pd468
[12]   Inhibition of C-protein-mediated MAP kinase activation by a new mammalian gene family [J].
Druey, KM ;
Blumer, KJ ;
Kang, VH ;
Kehrl, JH .
NATURE, 1996, 379 (6567) :742-746
[13]   The expanding spectrum of G protein diseases [J].
Farfel, Z ;
Bourne, HR ;
Iiri, T .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (13) :1012-1020
[14]   RGSZ1, a Gz-selective regulator of G protein signaling whose action is sensitive to the phosphorylation state of Gzα [J].
Glick, JL ;
Meigs, TE ;
Miron, A ;
Casey, PJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (40) :26008-26013
[15]  
Granneman JG, 1998, MOL PHARMACOL, V54, P687
[16]   Ligand binding pocket of the human somatostatin receptor 5: Mutational analysis of the extracellular domains [J].
Greenwood, MT ;
Hukovic, N ;
Kumar, U ;
Panetta, R ;
Hjorth, SA ;
Srikant, CB ;
Patel, YC .
MOLECULAR PHARMACOLOGY, 1997, 52 (05) :807-814
[17]   GROWTH-RATE-DEPENDENT REGULATION OF THE EXPRESSION AND INACTIVATION OF THYMIDYLATE SYNTHASE IN SACCHAROMYCES-CEREVISIAE [J].
GREENWOOD, MT ;
CALMELS, EM ;
STORMS, RK .
JOURNAL OF BACTERIOLOGY, 1986, 168 (03) :1336-1342
[18]   SEQUENCE-ANALYSIS OF THE 5'-FLANKING PROMOTER REGION OF THE HUMAN SOMATOSTATIN RECEPTOR-5 [J].
GREENWOOD, MT ;
PANETTA, R ;
ROBERTSON, LA ;
LIU, JL ;
PATEL, YC .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 205 (03) :1883-1890
[19]  
Gudermann T, 1996, ANNU REV PHARMACOL, V36, P429
[20]   RGS9, a GTPase accelerator for phototransduction [J].
He, W ;
Cowan, CW ;
Wensel, TG .
NEURON, 1998, 20 (01) :95-102